HIGHLIGHTS
- who: Haoqiang Lai from the (UNIVERSITY) have published the research work: Universal selenium nanoadjuvant with immunopotentiating and redox-shaping activities inducing high-quality immunity for SARS-CoV-2 vaccine, in the Journal: (JOURNAL) of 21/Nov/2022
- future: Actually the nanovaccine did not induce more generation of memory T/B cells compared to RBD and AL + RBD immunization groups (Supplementary Fig S10) and further studies to optimize the design is still required which is always the big challenge for nonviral-based vaccines.
SUMMARY
Received produce both TNF-α and IFN-γ than RBD . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.